Primary aldosteronism (Conn's syndrome) may be missed because definitive diagnostic procedures are complicated and screening tests using serum electrolytes or plasma renin activity are also unreliable.' Many laboratories rely on serum aldosterone and plasma renin activity measurements to confirm the diagnosis, but 24 hour urinary estimations have the advantage of providing an integrated reflection of the daily adrenal output of this hormone. 2' Free aldosterone in urine is present only in trace amounts, but one of its major metabolites, the 18 glucuronide conjugate, is present in much larger quantities. Hydrolysis of this conjugate, followed by purification and measurement of the released aldosterone, has formed the basis of most clinical assays.
Nowadays, this released aldosterone is usually measured by radioimmunoassay (RIA) methods, but such techniques are subject to inaccuracies caused by the crossreactivity of the antibodies with other steroids. 4 In the United Kingdom these estimations are largely confined to a few supraregional laboratories. 5 In this paper we describe a fluorimetric assay for urinary aldosterone which is a development of a method published by Whigham.6 It is highly specific and can be used where facilities for radioimmunoassays are not available. A major disadvantage of using 24 hour urine samples is that they are difficult to collect accurately. For this reason we measured aldosterone in overnight collections as well, because we felt that this might provide a more convenient test for primary aldosteronism.
Methods
Glass-distilled water was used for the aqueous reagents. Glassware was cleaned with the non-fluorescent detergent Decon 90 (Decon Laboratories Ltd, Hove, Sussex, England), and was treated with a silicone solution (Repelcote; BDH, Poole, Dorset) to prevent absorption of steroids on to glass. Pipettes were plugged with cotton wool to eliminate possible contamination from the pipette fillers.
All the chemicals and solvents were of AR grade (BDH). Dichloromethane was redistilled before use. A glycine buffer was made by dissolving 7*5 g glycine in about 200 ml of water which was taken to pH 3-5 with 6 M hydrochloric acid; the mixture was then diluted to 250 ml. Pure d-aldosterone was purchased from Sigma Chemicals, Poole, Dorset, and an accurate working standard of about 10 pmol/ml was prepared. Twenty four hour and overnight urine specimens were collected without preservative into polythene containers that had been washed with Decon. The overnight specimens were collected over 8 hour periods. Aliquots of about 30 ml were stored at -18°C. Five urine samples can be assayed in a single run.
ACID HYDROLYSIS
Aliquots (15 ml) of the urine samples and the working standard were transferred to glass tubes, taken to pH 1 with 6 M hydrochloric acid, and left for 22 hours in the dark at room temperature. We have confirmed that for hydrolysis times between 18 and 30 hours the amount of aldosterone released is constant.
FIRST EXTRACTION Dichloromethane (15 ml) was added to each tube and these were rotated horizontally for 30 minutes. The upper aqueous layers were aspirated and discarded, and the dichloromethane extracts were washed with 5 ml of 0 5 M sodium carbonate by agitating with a vortex mixer for 1 minute. Any emulsion formed was broken by this wash. The upper aqueous layers were aspirated and discarded, and the wash was repeated using 3 ml of water.
REMOVAL OF INTERFERING SUBSTANCES
A 10 ml aliquot of each extract was transferred to a clean tube and evaporated to dryness in a water bath at 56°C under a stream of nitrogen (99-9% pure, British Oxygen Company, England). The residue was dissolved by vortex in 3 ml of ethyl acetate. A water: ethanol mixture (9:1) was added (2 ml), followed by 20 ml of n-heptane, and the stoppered tubes were shaken vigorously on a flask shaker for 20 minutes. The upper n-heptane layers were aspirated and discarded. tested. None produced a peak on the chromatogram below an RF of 0 7. Urine was also assayed from patients receiving antihypertensive treatment: thiazide diuretics (n = 11); spironolactone (n = 7); fl-adrenoceptor blocking drugs (n = 5); calcium-channel blockers (n = 4); angiotensin converting enzyme inhibitors (n = 3). In no case was there any interfering peak on the chromatogram.
Results
Known amounts of aldosterone were taken through the method. The largest of these represents a concentration in a 24 hour urine about seven times the upper limit of normal. There was a linear correlation between the amount of aldosterone used and the area under the peak on the chromatogram (fig 2) .
Areas as small as 0 5 cm2 can be measured accurately on the chromatogram. This corresponds to about 6 pmol of aldosterone in the 15 ml urine sample. Thus the lower limit of sensitivity in a 24 hour urine sample with an average volume of 1-5 litres is about 0O6 nmolI24 hours, and in an overnight sample of 500 ml is 0-2 nmol/8 hours.
The mean recovery of 66-5 pmol of aldosterone added to urine was 94-2%, with a range of 77-8 to 106-0% on 10 estimations. When a sample was assayed five times on a single plate, the mean intra-assay coefficient of variation was 4-4% for five separate runs. When another sample was measured on 20 occasions on different days, the interassay coefficient of variation was 6-8%. Normal values for 24 hour and overnight aldosterone excretions were obtained from a group of healthy adults and ambulant patients on unrestricted diets. The latter were normotensive and not taking any medication. There were roughly equal numbers of men and women, and their ages ranged from 17 to 75 years (mean 43 years). There was no significant difference between the excretion in men or women, nor between the healthy individuals and the patients, so that the subjects were regarded as a single group. The mean (SD) value for the 24 hour aldosterone excretion in 67 adults was 15-7 (8-1) nmol/24 hours with an upper limit of 38-5 nmol/24 hours. The mean overnight concentration in 65 adults was 2-6 (1-4) nmol/8 hours, the upper limit being 6-9 nmol/8 hours.
When ranked according to age, there were no significant differences in the mean 24 hour or overnight concentrations from the third to the seventh decade of life (table 1) . The average amount of aldosterone excreted at night was less than 20% of the total 24 hour output.
ABNORMAL ADRENAL FUNCTION
To test the validity of the method, specimens of urine were collected from patients with abnormal adrenal function. Low concentrations were found in seven patients with adrenal insufficiency resulting from Addison's disease (n = 1), congenital adrenal hyperplasia (n = 1), hypopituitarism (n = 3), and following bilateral adrenalectomy (n = 2). The mean (SD) concentration in this group was only (1-4) nmolI24 hours.
Increased concentrations were found in three patients with primary aldosteronism, in four patients with secondary aldosteronism attributed to diuretic treatment, and in two patients with Cushing's syndrome who presented with hypokalaemia (fig 3) . In the seven patients with raised overnight concentrations the proportion excreted at night ranged from 17% to 46% (mean 34%) of the total 24 hour output.
Discussion
The major advantages of the method described in this paper are its good specificity and accuracy. The use of thin-layer chromatography before fluorimetric detection ensures that the identity of the peak produced by the oxidised aldosterone can be verified. Up to five urine samples may be assayed in a single run, but the method could be modified to accommodate a larger number of samples by increasing the width of the chromatography plate. Results can be obtained within two working days, and the method takes about three hours of a technician's time.
Although antihypertensive drugs do not interfere with the assay, they may alter aldosterone production. It has been suggested that patients being investigated for primary aldosteronism should stop taking these drugs for at least two weeks beforehand, and in the case of spironolactone for at least six weeks. 8 The 
